Published by Coherent Market Insights
Posted on September 17, 2021
Continuous Glucose Monitoring (CGM) Devices Market Size And Forecast
The global continuous glucose monitoring (CGM) devices market was valued at US$ 3,807.3 million in 2018 and is expected to witness a robust CAGR of 24.8% over the forecast period (2019- 2027).
The continuous glucose monitoring (CGM) devices provide insights about the glucose levels of the diabetic patient throughout the day. CGM is mostly used by patients with type 1 and type 2 diabetes for better glucose control to improve the health and quality of their lives. Moreover, the integration of smartphone for easy diabetes management and cloud based data storage are the key features of the currently available CGM devices which have contributed to the drastic adoption of the CGM systems. The CGM devices displays a complete picture of glucose trends with a graphical display and customizable alerts to indicate the disturbances in glucose status.
Request for Analysis of COVID-19 Impact on Continuous Glucose Monitoring (CGM) Devices Market –
https://www.coherentmarketinsights.com/insight/request-sample/57
What are Continuous Glucose Monitoring (CGM) Devices?
A CGM works through a tiny sensor inserted under your skin, usually on your belly or arm. The sensor measures your interstitial glucose level, which is the glucose found in the fluid between the cells. The sensor tests glucose every few minutes. A transmitter wirelessly sends the information to a monitor. Continuous glucose monitoring automatically tracks blood glucose levels, also called blood sugar, throughout the day and night. You can see your glucose level anytime at a glance. You can also review how your glucose changes over a few hours or days to see trends. Seeing glucose levels in real time can help you make more informed decisions throughout the day about how to balance your food, physical activity, and medicines.
Request PDF Brochure Report –
https://www.coherentmarketinsights.com/insight/request-pdf/57
Global Continuous Glucose Monitoring (CGM) Devices Market Overview
Continuous Glucose Monitoring is an innovative non-intrusive method to measure long-term blood glucose control. The CGM instrument, an infrared sensor is attached to the fingertip of the individual taking the test. A small blood sample is first taken with a disposable applicator and then sent for analysis to a laboratory. A highly sensitive test known as quantitative blood testing (or QFT) is performed on the collected blood samples. A specific protocol for interpreting the results of the test is followed by the physician based on his findings. Continuous glucose monitoring device provides the doctor with important information about the condition of the patient. This is important because the doctor needs to make treatment decisions based on the observations of the patient.
Segmentation Analysis:
If opting for the Global version of Continuous Glucose Monitoring (CGM) Devices Market analysis is provided for major regions as follows:
North America (The US, Canada, and Mexico)
Europe (the UK, Germany, France, and Rest of Europe)
Asia Pacific (China, India, and Rest of Asia Pacific)
Latin America (Brazil and Rest of Latin America)
Middle East & Africa (Saudi Arabia, the UAE, South Africa, and Rest of Middle East & Africa)
Reasons to Purchase this Report
Current and future of global Continuous Glucose Monitoring (CGM) Devices market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/57
Competitive Landscape:
Medtronic, Dexcom, Inc
Medtrum Technologies, Inc
Tandem Diabetes Care
Abbott Laboratories
Senseonics
Insulet Corporation
Nemaura Medical, Inc
STMicroelectronics
Glycens
NXP Semiconductors
Taiwan Semiconductor Manufacturing Company Limited
Qualcomm
GE Healthcare
Microchip Technology Inc
Key Market Drivers:
The growing prevalence of diabetes is augmenting growth of the continuous glucose monitoring market. According to the American Diabetes Association, in 2018, 34.2 million Americans, or 10.5% of the population, had diabetes. Nearly 1.6 million Americans have type 1 diabetes, including about 187,000 children and adolescents. Of the 34.2 million adults with diabetes, 26.8 million were diagnosed, and 7.3 million were undiagnosed.
Continuous launch of new and advanced products is uplifting growth of the market. For instance, in March 2021, Roche has announced the launch of the new Accu-Chek Instant system, a new “connected” blood glucose monitoring (BGM) system, which supports and enables Roche’s approach of integrated Personalized Diabetes Management (iPDM).
Covid-19 Impact Analysis
With continuing spread of coronavirus infection, MedTech companies are slowly and gradually building their recessionary curve by leveraging technology. Various organizations are going through response, renewal, and recovery phases. Continuous launch of the product by organizations to retain their position in the market will helps key players to get out of the COVID-19 pandemic.
Key Takeaways:
The continuous glucose monitoring market is expected to exhibit a CAGR of XX % over the forecast period, owing to the increasing research & development activities in the field. For instance, in June 2021, Researchers tested the effectiveness of the two different monitoring devices in 175 participants with type 2 diabetes who were being treated with insulin. They observed that people with type 2 diabetes who use insulin may see more benefits from the device than from a traditional blood glucose monitor, for which they periodically prick their skin to test their blood sugar.
North America is expected to gain significant growth over the forecast period and this is attributed to the presence of strong players in the region. For instance, Medtronic, Abbott Laboratories, GE Healthcare, and Texas Instruments Inc. are some of the key players in the United States.
View Press Release For More Information
Major Point Answered in Continuous Glucose Monitoring (CGM) Devices Market Research Study are:
What will be the progress rate of the Continuous Glucose Monitoring (CGM) Devices Market for the conjecture period, 2020-2027?
What are the prominent factors driving the Continuous Glucose Monitoring (CGM) Devices Market across different regions?
Who are the major vendors dominating the Continuous Glucose Monitoring (CGM) Devices industry and what are their winning strategies?
What will be the market scope for the estimated period?
What are the major trends shaping the expansion of the industry in the coming years?
What are the challenges faced by the Continuous Glucose Monitoring (CGM) Devices Market?
Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report.
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Continuous Glucose Monitoring (CGM) Devices Market Worth USD 27.7 Billion by 2027 At a 24.8% CAGR | Companion for Efficient Diabetes Management toGenerate New Growth Opportunities: Coherent Market Insights™ appeared first on Gatorledger.
Continuous Glucose Monitoring (CGM) Devices Market Size And Forecast
The global continuous glucose monitoring (CGM) devices market was valued at US$ 3,807.3 million in 2018 and is expected to witness a robust CAGR of 24.8% over the forecast period (2019- 2027).
The continuous glucose monitoring (CGM) devices provide insights about the glucose levels of the diabetic patient throughout the day. CGM is mostly used by patients with type 1 and type 2 diabetes for better glucose control to improve the health and quality of their lives. Moreover, the integration of smartphone for easy diabetes management and cloud based data storage are the key features of the currently available CGM devices which have contributed to the drastic adoption of the CGM systems. The CGM devices displays a complete picture of glucose trends with a graphical display and customizable alerts to indicate the disturbances in glucose status.
Request for Analysis of COVID-19 Impact on Continuous Glucose Monitoring (CGM) Devices Market –
https://www.coherentmarketinsights.com/insight/request-sample/57
What are Continuous Glucose Monitoring (CGM) Devices?
A CGM works through a tiny sensor inserted under your skin, usually on your belly or arm. The sensor measures your interstitial glucose level, which is the glucose found in the fluid between the cells. The sensor tests glucose every few minutes. A transmitter wirelessly sends the information to a monitor. Continuous glucose monitoring automatically tracks blood glucose levels, also called blood sugar, throughout the day and night. You can see your glucose level anytime at a glance. You can also review how your glucose changes over a few hours or days to see trends. Seeing glucose levels in real time can help you make more informed decisions throughout the day about how to balance your food, physical activity, and medicines.
Request PDF Brochure Report –
https://www.coherentmarketinsights.com/insight/request-pdf/57
Global Continuous Glucose Monitoring (CGM) Devices Market Overview
Continuous Glucose Monitoring is an innovative non-intrusive method to measure long-term blood glucose control. The CGM instrument, an infrared sensor is attached to the fingertip of the individual taking the test. A small blood sample is first taken with a disposable applicator and then sent for analysis to a laboratory. A highly sensitive test known as quantitative blood testing (or QFT) is performed on the collected blood samples. A specific protocol for interpreting the results of the test is followed by the physician based on his findings. Continuous glucose monitoring device provides the doctor with important information about the condition of the patient. This is important because the doctor needs to make treatment decisions based on the observations of the patient.
Segmentation Analysis:
If opting for the Global version of Continuous Glucose Monitoring (CGM) Devices Market analysis is provided for major regions as follows:
North America (The US, Canada, and Mexico)
Europe (the UK, Germany, France, and Rest of Europe)
Asia Pacific (China, India, and Rest of Asia Pacific)
Latin America (Brazil and Rest of Latin America)
Middle East & Africa (Saudi Arabia, the UAE, South Africa, and Rest of Middle East & Africa)
Reasons to Purchase this Report
Current and future of global Continuous Glucose Monitoring (CGM) Devices market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/57
Competitive Landscape:
Medtronic, Dexcom, Inc
Medtrum Technologies, Inc
Tandem Diabetes Care
Abbott Laboratories
Senseonics
Insulet Corporation
Nemaura Medical, Inc
STMicroelectronics
Glycens
NXP Semiconductors
Taiwan Semiconductor Manufacturing Company Limited
Qualcomm
GE Healthcare
Microchip Technology Inc
Key Market Drivers:
The growing prevalence of diabetes is augmenting growth of the continuous glucose monitoring market. According to the American Diabetes Association, in 2018, 34.2 million Americans, or 10.5% of the population, had diabetes. Nearly 1.6 million Americans have type 1 diabetes, including about 187,000 children and adolescents. Of the 34.2 million adults with diabetes, 26.8 million were diagnosed, and 7.3 million were undiagnosed.
Continuous launch of new and advanced products is uplifting growth of the market. For instance, in March 2021, Roche has announced the launch of the new Accu-Chek Instant system, a new “connected” blood glucose monitoring (BGM) system, which supports and enables Roche’s approach of integrated Personalized Diabetes Management (iPDM).
Covid-19 Impact Analysis
With continuing spread of coronavirus infection, MedTech companies are slowly and gradually building their recessionary curve by leveraging technology. Various organizations are going through response, renewal, and recovery phases. Continuous launch of the product by organizations to retain their position in the market will helps key players to get out of the COVID-19 pandemic.
Key Takeaways:
The continuous glucose monitoring market is expected to exhibit a CAGR of XX % over the forecast period, owing to the increasing research & development activities in the field. For instance, in June 2021, Researchers tested the effectiveness of the two different monitoring devices in 175 participants with type 2 diabetes who were being treated with insulin. They observed that people with type 2 diabetes who use insulin may see more benefits from the device than from a traditional blood glucose monitor, for which they periodically prick their skin to test their blood sugar.
North America is expected to gain significant growth over the forecast period and this is attributed to the presence of strong players in the region. For instance, Medtronic, Abbott Laboratories, GE Healthcare, and Texas Instruments Inc. are some of the key players in the United States.
View Press Release For More Information
Major Point Answered in Continuous Glucose Monitoring (CGM) Devices Market Research Study are:
What will be the progress rate of the Continuous Glucose Monitoring (CGM) Devices Market for the conjecture period, 2020-2027?
What are the prominent factors driving the Continuous Glucose Monitoring (CGM) Devices Market across different regions?
Who are the major vendors dominating the Continuous Glucose Monitoring (CGM) Devices industry and what are their winning strategies?
What will be the market scope for the estimated period?
What are the major trends shaping the expansion of the industry in the coming years?
What are the challenges faced by the Continuous Glucose Monitoring (CGM) Devices Market?
Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report.
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Continuous Glucose Monitoring (CGM) Devices Market Worth USD 27.7 Billion by 2027 At a 24.8% CAGR | Companion for Efficient Diabetes Management toGenerate New Growth Opportunities: Coherent Market Insights™ appeared first on Gatorledger.
Explore more articles in the Research Reports category
